Comparison

Fosaprepitant dimeglumine European Partner

Item no. HY-14407A-50mg
Manufacturer MedChem Express
CASRN 265121-04-8
Amount 50 mg
Category
Type Inhibitors
Purity 99.0
Formula C37H56F7N6O16P
Citations New J Chem. 29th November 2021.
Cancer Biol Ther. 2019;20(5):653-665.
[1]Pranav Prasoon, et al. Role of fosaprepitant, a neurokinin Type 1 receptor antagonist, in morphine-induced antinociception in rats. Indian J Pharmacol. 2016 Jul-Aug; 48(4): 394-398.
Smiles O=C1N=C(CN2[C@@H](C3=CC=C(F)C=C3)[C@@H](O[C@H](C)C4=CC(C(F)(F)F)=CC(C(F)(F)F)=C4)OCC2)NN1P(O)(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CNC.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CNC
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias MK-0517; L785298
Available
Product Description
Fosaprepitant dimeglumine (MK-0517) is a proagent of Aprepitant (HY-10052). Fosaprepitant dimeglumine is a neurokinin-1 receptor antagonist, which is development for the prevention of chemotherapy-induced nausea and vomiting (CINV)[1].
StorageTemperature
4°C (Powder, sealed storage, away from moisture)
Shipping
Room Temperature
Manufacturers Applications
Cancer-programmed cell death
Molecular Weight
1004.83
Clinical Information
Launched
Solubility
10 mM in DMSO|H2O : 50 mg/mL (ultrasonic)
Pathway
GPCR/G Protein; Neuronal Signaling
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close